Pfizer to shutdown Chennai, Aurangabad plants, may impact 1700 employees

By: Pharma Tips | Views: 3729 | Date: 10-Jan-2019

US-druggaint Pfizer will be soon be shutting down two of itsplants in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai inTamil Nadu citing lack of viability.Both the plants are export-oriented and came under Pfizer's ownership after it acquired US-based drug maker Hospira in a $17-billion deal in February 2015.

US-drug gaint Pfizer will be soon be shutting down two of its plants in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing lack of viability.

The exact timing of the exit of the sites is yet to be determined.

The two sites employee about 1700 people.

Both the plants are export-oriented and came under Pfizer's ownership after it acquired US-based drug maker Hospira in a $17-billion deal in February 2015.

"Earlier today we announced to colleagues at our Aurangabad and IKKT sites in India that we will immediately cease manufacturing at the sites with the intention to exit both the sites as soon as possible in 2019," according to an internal note shared with the employees.

"Following a thorough evaluation of these sites, we concluded that due to the very significant long-term loss of product demand, manufacturing at these sites in not viable," the note said.

"We recognise that this is very difficult news for our colleagues there, and we will work closely with them during this transition," the note said.

Pfizer suspended manufacturing at IKKT due to USFDA observations. IKKT produces generic injectable antibiotics such as cephalosporins, penems and pencillins for the US, EU and other global markets.

The plant got 11 observations from the regulator following inspections in March-April last year.

The plant has been under USFDA scanner for a while. It was served with warning letter in May 2013 for significant violations of good manufacturing practices.

Aurangabad plant supplies penicillin and penem active pharmaceutical ingredients.

Following the closure of these two plants, Pfizer will be left with manufacturing sites in Goa, Visakhapatnam and a joint venture plant in Ahmedabad that makes cancer medicines.

Pfizer secured the Goa facility after acquiring Wyeth. The Visakhapatnam site is a greenfield factory in which Pfizer invested around $375-450 million to make injectables.

The company said that the announcement does not directly impact operations at other sites.

Pfizer in 2015 sold its oldest plant in Navi Mumbai for Rs 178 crore following an assessment of its long term viability and its ability to meet production targets. The 80 odd employees were given volutary retirement.

While Goa and Visakhapatnam are meant for exports, Pfizer relies on third party production facilitates for its India formulation business.

Previous Page Next Page

People Searching On This Page:
  • nmt4
  • aurangabad pfizer employee settlements

Related Pages


Walk-in Interview for B.Pharm, M.Pharma, BSC, MSC in Pfizer

Walk-in Interview for B.Pharm, M.Pharma, BSC, MSC in Pfizer

Jobs
Date:
12-Jul-2017  Views: 9115

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and ...
GST Impact on Pharmaceutical Industry

GST Impact on Pharmaceutical Industry

News
Date:
30-Mar-2017  Views: 47634

The long awaited Goods and Services tax (GST) Bill has been passed by both houses of India. There will be significant improvement in Indian Pharmaceut ...
Pfizer will close two U.K. plants, cut 370 jobs

Pfizer will close two U.K. plants, cut 370 jobs

News | Pharma Companies
Date:
18-Nov-2016  Views: 3302

Pfizer ($PFE) will close a couple of plants in the U.K., with more than 370 jobs on the line, but the U.S. company wants everyone to know that its exi ...
Preparation of Implants

Preparation of Implants

Articles | Pharmaceutics
Date:
04-Jul-2011  Views: 5800

Although many polymers can by used to prepare rate-limiting membranes for controlled release relatively few are employed for implantation purpose beca ...
Techniques of Biotechnology for Medicinal Plants

Techniques of Biotechnology for Medicinal Plants

Articles | Biology | Biotechnology
Date:
01-May-2011  Views: 4258

Biotransformation is a process through which the functional groups of organic compounds are modified by living cells. This process can be done by usin ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

13  + 6 =     
Comments
Narendra Uddhaorao gondane  |  14-Sep-2019 22:18:06 IST
I have 3 year exprience of phrma company. This is complitly real desision sir you are find it.I can create value my knowledge than you are an company. Other vise please guide me.
People Searched About:
Nmt4   |   Aurangabad Pfizer Employee Settlements   |  
Google : 91 times | Yahoo : 35 times | Bing : 77 times |